Radiopharm Theranostics
Business Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
62 Lygon St L 3, Carlton South, Victoria...Phone Number
+61 398245254Revenue
<$5 MillionStock Symbol
RADIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Radiopharm Theranostics
Radiopharm Theranostics, founded in 2021, is a research and development company focused on creating radiopharmaceutical products for both diagnostic and therapeutic applications. The company specializes in developing innovative solutions for areas with significant unmet medical needs, combining radioactive compounds with targeting molecules to diagnose and treat diseases. Radiopharm Theranostics operates in multiple locations and maintains a strong focus on technological advancement in the medical and healthcare sectors.Explore more
Radiopharm Theranostics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Radiopharm Theranostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Radiopharm Theranostics is spiking on competitors!
Funding: Get notified immidiatlly once Radiopharm Theranostics has new funding data
Click to see if Radiopharm Theranostics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Radiopharm Theranostics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Radiopharm Theranostics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Radiopharm Theranostics
Product Launch: Get notified when Radiopharm Theranostics launches new products
Radiopharm Theranostics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Radiopharm Theranostics
Find 3 more new buyers
Compare Similar Companies to Radiopharm Theranostics
Compare insights from companies similar to Radiopharm Theranostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Radiopharm Theranostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Radiopharm Theranostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Radiopharm Theranostics.
Radiopharm Theranostics financials insights
Gather financial insights about Radiopharm Theranostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Private Equity
$70M
Radiopharm Theranostics Tech Stack
A closer look at the technologies used by Radiopharm Theranostics
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Radiopharm Theranostics News & Media
Radiopharm Theranostics (RADX) CMO discloses multi‑million share option grants
Radiopharm Theranostics CMO Dimitris Voliotis reports three low‑priced option positions over millions of Ordinary Shares, with exercise dates from 2026 to 2028 and a 2030 expiry.Radiopharm Theranostics updates CFO and secretaries | RADX SEC Filing - Form 6-K
Radiopharm Theranostics announces the resignation of CFO Phillip Hains, appoints Aaron Laurita as CFO, and adds Amritha Sushil as Joint Company Secretary alongside Nathan Jong.Radiopharm Theranostics Reports Business Update
Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier announcement of interim data demonstrating concordance with MRI (the primary endpoint) in 90% of evaluable subjects (18/20)Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
177Lu-RAD202 demonstrated encouraging tumor uptake and a favorable safety profile in the lowest dose cohort
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Radiopharm Theranostics
Sign Up For FreeTo access detailed company insights
Radiopharm Theranostics, founded in 2021, is a research and development company focused on creating radiopharmaceutical products for both diagnostic and therapeutic applications. The company specializes in developing innovative solutions for areas with significant unmet medical needs, combining radioactive compounds with targeting molecules to diag... Read More
